Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander T Cohen

Showing results (51-60 of 227) with videos related to

Pageof 23
Sort By:
American Journal of Hematology|July 13, 2007
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolismFrederick A Anderson, Maxim Zayaruzny, John A Heit, et al.
Pharmacological Research|March 26, 2019
Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analysesAlexander T Cohen, Samantha E Berger, Dušan Milenković, et al.
Journal of the American Heart Association|December 3, 2015
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) TrialXianchen Liu, Margot Johnson, Jack Mardekian, et al.
Heart (British Cardiac Society)|August 27, 2015
Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013Carlos Martinez, Anja Katholing, Christopher Wallenhorst, et al.
Thrombosis and Haemostasis|August 1, 2023
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active CancerAlexander T Cohen, Christopher Wallenhorst, Satarupa Choudhuri, et al.
Journal of Thrombosis and Thrombolysis|February 6, 2016
Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism StudyWei Huang, Robert J Goldberg, Frederick A Anderson, et al.
Current Medical Research and Opinion|May 25, 2021
Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancerAlexander T Cohen, Allison Keshishian, Theodore Lee, et al.
Thrombosis Research|September 11, 2017
The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell diseaseMarije Wijnberge, Kiran Parmar, Rachel Kesse-Adu, et al.
Frontiers in Neurology|March 13, 2023
Derivation and validation of a composite scoring system (SAVED<sub>2</sub>) for prediction of unfavorable modified Rankin scale score following intracerebral hemorrhageCraig I Coleman, Mauricio Concha, Bruce Koch, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2023
Bleeding related hospitalizations and mortality in England 2014-2019Katherine J Creeper, Andrew C Stafford, Satarupa Choudhuri, et al.
Pageof 23

Showing results (51-60 of 227) with videos related to

Sort By:
Pageof 23
American Journal of Hematology|July 13, 2007
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolismFrederick A Anderson, Maxim Zayaruzny, John A Heit, et al.
Pharmacological Research|March 26, 2019
Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analysesAlexander T Cohen, Samantha E Berger, Dušan Milenković, et al.
Journal of the American Heart Association|December 3, 2015
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) TrialXianchen Liu, Margot Johnson, Jack Mardekian, et al.
Heart (British Cardiac Society)|August 27, 2015
Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013Carlos Martinez, Anja Katholing, Christopher Wallenhorst, et al.
Thrombosis and Haemostasis|August 1, 2023
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active CancerAlexander T Cohen, Christopher Wallenhorst, Satarupa Choudhuri, et al.
Journal of Thrombosis and Thrombolysis|February 6, 2016
Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism StudyWei Huang, Robert J Goldberg, Frederick A Anderson, et al.
Current Medical Research and Opinion|May 25, 2021
Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancerAlexander T Cohen, Allison Keshishian, Theodore Lee, et al.
Thrombosis Research|September 11, 2017
The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell diseaseMarije Wijnberge, Kiran Parmar, Rachel Kesse-Adu, et al.
Frontiers in Neurology|March 13, 2023
Derivation and validation of a composite scoring system (SAVED<sub>2</sub>) for prediction of unfavorable modified Rankin scale score following intracerebral hemorrhageCraig I Coleman, Mauricio Concha, Bruce Koch, et al.
Journal of Thrombosis and Thrombolysis|June 20, 2023
Bleeding related hospitalizations and mortality in England 2014-2019Katherine J Creeper, Andrew C Stafford, Satarupa Choudhuri, et al.
Pageof 23